Literature DB >> 14984959

An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.

Kate Brain1, Clare Gravell, Elizabeth France, Alison Fiander, Jonathon Gray.   

Abstract

OBJECTIVE: Women who are at increased risk of familial ovarian cancer face complex decisions about strategies for managing their risk due to a lack of evidence regarding the benefits of ovarian cancer screening (OCS) and prophylactic surgery. At present, there is a limited understanding of women's attitudes towards these options.
METHOD: In-depth interviews were conducted to explore perceptions of ovarian cancer screening and prophylactic oophorectomy (PO) in 10 women who were newly identified as being at increased risk of familial ovarian cancer.
RESULTS: The study findings highlight the gaps in women's knowledge about risk management options. Although most women derived considerable reassurance from ovarian screening, many were not aware of the limitations of the screening process or the likelihood of receiving false positive results. Areas in which women's knowledge about prophylactic oophorectomy could be improved include the practicalities of surgery, the risks and benefits of HRT given postsurgically, the limitations of surgery in removing risk, and the absence of concrete information on which to base surgical decisions. In particular, women who were not previously aware of their increased risk may need additional psychological support and preparation.
CONCLUSIONS: The present study raises serious questions about the extent to which women are making informed decisions about familial ovarian cancer risk management strategies. Suggestions are made for improving the information and support provided to women and for large-scale prospective research.

Entities:  

Mesh:

Year:  2004        PMID: 14984959     DOI: 10.1016/j.ygyno.2003.12.019

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

2.  Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

Authors:  Kate J Lifford; Alison Clements; Lindsay Fraser; Deborah Lancastle; Kate Brain
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

3.  Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Laura Tamutis; Lesa Dawson
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

4.  Understanding the needs of women considering risk-reducing salpingo-oophorectomy.

Authors:  Carol Cherry; Mary Ropka; Jennifer Lyle; Laura Napolitano; Mary B Daly
Journal:  Cancer Nurs       Date:  2013 May-Jun       Impact factor: 2.592

Review 5.  Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff
Journal:  J Genet Couns       Date:  2009-10-03       Impact factor: 2.537

6.  Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  L Fallowfield; A Fleissig; J Barrett; U Menon; I Jacobs; J Kilkerr; V Farewell
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

7.  Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

Authors:  A Fuchsia Howard; Joan L Bottorff; Lynda G Balneaves; Charmaine Kim-Sing
Journal:  BMC Womens Health       Date:  2010-08-05       Impact factor: 2.809

8.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Kathy Watkins; Sabrina Alani; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2015-03-19       Impact factor: 2.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.